Ann: Phosphagenics Newsletter - August 2018, page-30

First 30 Last

Share
Profile

Follow
playez

4,180 Posts.

68

20/08/18

15:04

Post #: 35040065
Share

Originally posted by kens ↑

As has been previously higlighted from the newsletter:
"I would also like shareholders to again note that the that the ongoing existence of the Licensing Agreement between our company and Mylan Laboratories Limited will not be impacted by the arbitration outcome and will continue to be in force. Our company therefore continues to work within, and actively protect our rights under, the Licensing Agreement'".
My understanding of the Mylan arbitration event is that the arbitrator refers to any matters presented to the arbitrator up to and including final submissions and that any matters arising after that time cannot be submitted and therefore should have no impact on the arbitration end result.
If the above newsletter statement is correct[and I hope it it is] and the POH total daptomycin damages claim of US $300K includes forward looking loss estimates, I am finding it difficult to understand that the above statement does represent a form of double dipping.If it is not double dipping then a positive outcome here could exceed all of my current expectations which is probably why RM has raised the matter in the first place.
Kens

Expand

Double dipping or cake and eat it to kens .
Proving value and therefore loss when something has only value when held by another and not the owner .
Sounds like a contender for a Nobel in economics .

POH Price at posting: 1.8¢ Sentiment: Hold Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Making money: How many microcaps should be in an investor's portfolio?

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

There are more pages in this discussion • 22 more messages in this thread...

First 30 Last

Add AVE (ASX) to my watchlist

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $6.338M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$26	13K

Buyers (Bids)

No.	Vol.	Price($)
12	6848102	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	41925822	29

View Market Depth

No.	Vol.	Price($)
12	6848102	0.002
26	68117741	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	41925822	29
0.004	16347566	14
0.005	10075266	8
0.006	11115082	11
0.007	13229103	6

Last trade - 10.58am 01/11/2024 (20 minute delay)

AVE (ASX) Chart

Ann: Phosphagenics Newsletter - August 2018, page-30

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Making money: How many microcaps should be in an investor's portfolio?

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Phosphagenics Newsletter - August 2018, page-30

Top Stories

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Making money: How many microcaps should be in an investor's portfolio?

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News